Results 191 to 200 of about 153,261 (262)

The mind-body connection in women's reproductive health: how psychological stress shapes gut and ovarian function - a narrative review. [PDF]

Front Gastroenterol (Lausanne)
Yachanahalli Purushotham A, Shilpa BM, Sundaram D.   +2 more
europepmc   +1 more source

Incretin‐Based Therapies: A Testable Hypothesis Linking Incretin Signaling, Mitochondrial Redox, and OXPHOS Efficiency

Obesity, EarlyView.
ABSTRACT Objective Incretin‐based obesity therapies (IBTs), especially GLP‐1 receptor agonists (GLP‐1 RAs), effectively treat obesity and improve comorbidities. However, their impact on energy metabolism is unclear. A recent case of acute generalized muscle weakness in a patient with mitochondrial myopathy after tirzepatide exposure raises concerns ...
Bryn Falahee, Caroline M. Apovian, Nawfal Istfan   +2 more
wiley   +1 more source

A third ventricular floor-associated TTF-1-positive posterior pituitary tumor: illustrative case. [PDF]

J Neurosurg Case Lessons
Zhang Z, Wang B, Wu X, Zhao H, Guan W, Zhang Y, Tang Y, Li S.   +7 more
europepmc   +1 more source

Hospitalization Utilization Metric After Major Oncologic Head and Neck Surgery With Microvascular Free Flap

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective The primary length of stay (PLOS) metric fails to capture added time, costs, and reduced patient quality of life (QOL) associated with readmissions. To address these limitations, we propose a novel metric, the hospitalization utilization metric (HUM), which integrates PLOS and readmission LOS (RLOS). Study Design Retrospective review
Nana‐Hawwa Abdul‐Rahman, Anthony Tang, Zainab Balogun, Alexandria Harris, Shaum Sridharan, Matthew E. Spector, Carl H. Snyderman   +6 more
wiley   +1 more source

Immune checkpoint inhibitor-related endocrinopathies: from immune crosstalk to predictive biomarkers and precision management. [PDF]

Front Endocrinol (Lausanne)
Liu Y, Xu T, Chen Z, Zhang W, Wang T, Yan W, Xie Y, Li H, Cai X.   +8 more
europepmc   +1 more source

Growth hormone-releasing hormone, growth hormone, and neuroendocrine tumors. [PDF]

J Clin Transl Endocrinol
Shahid M, Koch CA.
europepmc   +1 more source

Acromegaly is associated with an increased incidence of primary malignant tumors: data from a national study in Sweden.

J Clin Endocrinol Metab
Tsatsaris E, Robèrt J, Burman P, Berinder K, Bonelli L, Dahlqvist P, Höybye C, Ragnarsson O, Vouzouneraki K, Åkerman AK, Ekman B, Engström BE.   +11 more
europepmc   +1 more source